The role and mechanism of rosiglitazone in endothelial-to-mesenchymal transition in pulmonary hypertension
{{output}}
Objective: Pulmonary hypertension (PH) involves endothelial-to-mesenchymal transition (EndMT) in vascular remodeling. Rosiglitazone (RSG), a peroxisome proliferator-activated receptor gamma agonist, alleviates PH, but its direct ... ...
